PSME3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.279000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.329200E-01
Normal-vs-Stage2
9.535000E-01
Normal-vs-Stage3
1.924970E-01
Normal-vs-Stage4
3.799000E-01
Stage1-vs-Stage2
7.897200E-01
Stage1-vs-Stage3
6.536100E-02
Stage1-vs-Stage4
3.390000E-01
Stage2-vs-Stage3
7.613700E-02
Stage2-vs-Stage4
2.944600E-01
Stage3-vs-Stage4
6.653600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.120400E-01
Normal-vs-AfricanAmerican
5.457200E-01
Normal-vs-Asian
5.166400E-01
Caucasian-vs-AfricanAmerican
2.377800E-01
Caucasian-vs-Asian
3.165200E-01
AfricanAmerican-vs-Asian
1.290200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.228000E-01
Normal-vs-Female
9.344000E-01
Male-vs-Female
8.933800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.610000E-01
Normal-vs-Age(41-60Yrs)
7.636200E-01
Normal-vs-Age(61-80Yrs)
7.924800E-01
Normal-vs-Age(81-100Yrs)
9.658600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.216600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.318000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.920000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.898000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.271800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.663800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.915400E-01
Normal-vs-Daily Drinker
3.561400E-01
Normal-vs-Weekly Drinker
9.088200E-01
Normal-vs-Occasional Drinker
5.489400E-01
Normal-vs-Social Drinker
9.459400E-01
Non Drinker-vs-Daily Drinker
3.705000E-01
Non Drinker-vs-Weekly Drinker
4.914800E-01
Non Drinker-vs-Occasional Drinker
1.175370E-01
Non Drinker-vs-Social Drinker
4.132200E-01
Daily Drinker-vs-Weekly Drinker
8.961900E-02
Daily Drinker-vs-Occasional Drinker
5.775900E-03
Daily Drinker-vs-Social Drinker
2.878200E-02
Weekly Drinker-vs-Occasional Drinker
5.335400E-01
Weekly Drinker-vs-Social Drinker
8.652400E-01
Occasional Drinker-vs-Social Drinker
2.667800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.936200E-01
Normal-vs-Grade 2
1.302220E-01
Normal-vs-Grade 3
5.876400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.470600E-01
Grade 1-vs-Grade 3
1.581600E-01
Grade 1-vs-Grade 4
2.936200E-01
Grade 2-vs-Grade 3
6.398400E-01
Grade 2-vs-Grade 4
1.302220E-01
Grade 3-vs-Grade 4
5.876400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.301600E-01
Normal-vs-NonDiabetic
9.676800E-01
Diabetic-vs-NonDiabetic
6.795700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.308400E-01
Normal-vs-NoPancreatitis
8.457200E-01
Pancreatitis-vs-NoPancreatitis
6.145400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.438200E-01
Normal-vs-N1
9.688400E-01
N0-vs-N1
6.423800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.713200E-01
Normal-vs-TP53-NonMutant
8.970400E-01
TP53-Mutant-vs-TP53-NonMutant
1.791750E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
